M

Mega Lifesciences PCL
SET:MEGA

Watchlist Manager
Mega Lifesciences PCL
SET:MEGA
Watchlist
Price: 34.25 THB 0.74%
Market Cap: 29.9B THB
Have any thoughts about
Mega Lifesciences PCL?
Write Note

Mega Lifesciences PCL
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mega Lifesciences PCL
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
M
Mega Lifesciences PCL
SET:MEGA
Capital Expenditures
-฿272.8m
CAGR 3-Years
-17%
CAGR 5-Years
22%
CAGR 10-Years
-3%
B
Bangkok Lab and Cosmetic PCL
SET:BLC
Capital Expenditures
-฿60.3m
CAGR 3-Years
-21%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
No Stocks Found

Mega Lifesciences PCL
Glance View

Market Cap
29.9B THB
Industry
Pharmaceuticals

Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.

MEGA Intrinsic Value
53.53 THB
Undervaluation 36%
Intrinsic Value
Price
M

See Also

What is Mega Lifesciences PCL's Capital Expenditures?
Capital Expenditures
-272.8m THB

Based on the financial report for Sep 30, 2024, Mega Lifesciences PCL's Capital Expenditures amounts to -272.8m THB.

What is Mega Lifesciences PCL's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-3%

Over the last year, the Capital Expenditures growth was 5%. The average annual Capital Expenditures growth rates for Mega Lifesciences PCL have been -17% over the past three years , 22% over the past five years , and -3% over the past ten years .

Back to Top